ICCC News and Press, ImmuCell Corporation

PORTLAND, Maine, Feb. 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, expects to report unaudited fi...

2026-01-09 12:24:49 ET ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call January 9, 2026 9:00 AM EST... Read the full article on Seeking Alpha For further details see: ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call Transcript

2026-01-08 16:28:29 ET More on ImmuCell ImmuCell Corporation (ICCC) Q3 2025 Earnings Call Transcript ImmuCell Corporation: At A Major Inflection Point ImmuCell signals operational excellence and targets $30M annual production capacity amid management transition ...

PORTLAND, Maine, Jan. 08, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, today announced prelimina...

PORTLAND, Maine, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, plans to conduct a conference ...

PORTLAND, Maine, Dec. 24, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity today announced that it received an Incomplete Letter fro...

2025-11-14 11:02:21 ET More on ImmuCell ImmuCell Corporation (ICCC) Q3 2025 Earnings Call Transcript ImmuCell Corporation: At A Major Inflection Point mmuCell appoints Olivier te Boekhorst as new CEO ImmuCell announces preliminary sales results for Q3 ...

2025-11-14 11:01:37 ET ImmuCell Corporation (ICCC) Q3 2025 Earnings Call November 14, 2025 9:00 AM EST Company Participants Michael Brigham - Special Advisor to the CEO & Director P. F. Te Boekhorst - President, CEO & Director Timothy Fiori - CFO, Secretary...

2025-11-13 16:19:07 ET More on ImmuCell ImmuCell Corporation: At A Major Inflection Point mmuCell appoints Olivier te Boekhorst as new CEO ImmuCell announces preliminary sales results for Q3 Seeking Alpha’s Quant Rating on ImmuCell Financial in...

PORTLAND, Maine, Nov. 13, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health a...